Presbyterian Health Foundation

The foundation is governed by a board of directors, but no specific named CEO, president, or executive director is listed in public sources. The board likely includes local healthcare and philanthropic leaders, though individual names are not widely published. Grant decisions are made through a formal process reviewed by the board (per the foundation's public records).

The Presbyterian Health Foundation is a charitable foundation that makes grants, not investments. It does not appear to hold equity in portfolio companies or operate a venture capital arm. Its giving is concentrated on equipment, research funding, and facilities at Oklahoma-based institutions.

The foundation funds biomedical research infrastructure—including equipment purchases and building construction—as well as early-stage investigator projects and technology transfer initiatives. It also supports community health programs and medical education in Oklahoma. Grants have benefited the Oklahoma Medical Research Foundation and the University of Oklahoma Health Sciences Center (per the Oklahoma Medical Research Foundation, 2023).

The foundation was capitalized through the sale of Presbyterian Hospital to Columbia/HCA in 1994. Its endowment is primarily invested in financial assets, and the foundation distributes a portion of its earnings each year as grants. No other major wealth source has been publicly disclosed.

Yes, the foundation's grantmaking is geographically restricted to Oklahoma. This is a structural constraint that focuses its impact within the state, supporting local research institutions and health initiatives.

No publicly disclosed affiliated for-profit entities or operating businesses exist. The foundation operates solely as a grantmaking organization.

Unlike venture philanthropy funds that take equity stakes in early-stage companies, the Presbyterian Health Foundation makes pure grants without seeking financial return. Its model is closer to a traditional private foundation, funding research and facilities rather than commercializing technologies directly.